Neurovascular Devices Market by Disease Pathology (Aneurysm, Arteriovenous Malformation & Fistulas, Ischemic Stroke), Devices (Cerebral Angioplasty & Stenting Systems, Cerebral Embolization & Aneurysm Coiling Devices, Neurothrombectomy Devices), End-User

Neurovascular Devices Market by Disease Pathology (Aneurysm, Arteriovenous Malformation & Fistulas, Ischemic Stroke), Devices (Cerebral Angioplasty & Stenting Systems, Cerebral Embolization & Aneurysm Coiling Devices, Neurothrombectomy Devices), End-User - Global Forecast 2024-2030


The Neurovascular Devices Market size was estimated at USD 3.21 billion in 2023 and expected to reach USD 3.44 billion in 2024, at a CAGR 7.34% to reach USD 5.28 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neurovascular Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neurovascular Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, AngioDynamics Inc., Artio Medical, Inc., B. Braun Melsungen AG, BALT Group, Boston Scientific Corporation, Cerus Endovascular Inc., CONMED Corporation, Cook Medical Group, Endologix Inc., Evasc Medical Systems Corp., Integra Lifesciences Corporation, iVascular S.L.U., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medical Murray, Medtronic PLC, Microvention Inc., Penumbra, Inc., Phenox GmbH by Wallaby Medical, Rapid Medical Ltd., Scientia Vascular, Inc., Secant Group, LLC, Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zeus Company Inc..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Disease Pathology

Aneurysm

Arteriovenous Malformation & Fistulas

Ischemic Stroke

Stenosis
Devices

Cerebral Angioplasty & Stenting Systems
Embolic Coils
Flow Diverters
Liquid Embolic Agents

Cerebral Embolization & Aneurysm Coiling Devices
Carotid Artery Stents
Embolic Protection Systems

Neurothrombectomy Devices
Clot Retrieval Devices
Suction Devices
Vascular Snares

Support Devices
Micro Catheters
Micro Guidewires
End-User

Ambulatory Surgical Centers

Hospitals

Specialized Clinics
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Neurovascular Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neurovascular Devices Market?
3. What are the technology trends and regulatory frameworks in the Neurovascular Devices Market?
4. What is the market share of the leading vendors in the Neurovascular Devices Market?
5. Which modes and strategic moves are suitable for entering the Neurovascular Devices Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Neurovascular Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of a brain aneurysm and neurological disorders
5.1.1.2. Rising demand for minimally invasive procedures for brain surgeries
5.1.2. Restraints
5.1.2.1. High cost associated with the neurovascular interventions and devices
5.1.3. Opportunities
5.1.3.1. Emerging research activities and technological advancements in the field of neurovascular therapies
5.1.3.2. Ongoing product development and approvals of neurovascular devices
5.1.4. Challenges
5.1.4.1. Limited availability of neurosurgeons across the globe
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Neurovascular Devices Market, by Disease Pathology
6.1. Introduction
6.2. Aneurysm
6.3. Arteriovenous Malformation & Fistulas
6.4. Ischemic Stroke
6.5. Stenosis
7. Neurovascular Devices Market, by Devices
7.1. Introduction
7.2. Cerebral Angioplasty & Stenting Systems
7.3.1. Embolic Coils
7.3.2. Flow Diverters
7.3.3. Liquid Embolic Agents
7.3. Cerebral Embolization & Aneurysm Coiling Devices
7.4.1. Carotid Artery Stents
7.4.2. Embolic Protection Systems
7.4. Neurothrombectomy Devices
7.5.1. Clot Retrieval Devices
7.5.2. Suction Devices
7.5.3. Vascular Snares
7.5. Support Devices
7.6.1. Micro Catheters
7.6.2. Micro Guidewires
8. Neurovascular Devices Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialized Clinics
9. Americas Neurovascular Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Neurovascular Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Neurovascular Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Acandis GmbH
13.1.2. AngioDynamics Inc.
13.1.3. Artio Medical, Inc.
13.1.4. B. Braun Melsungen AG
13.1.5. BALT Group
13.1.6. Boston Scientific Corporation
13.1.7. Cerus Endovascular Inc.
13.1.8. CONMED Corporation
13.1.9. Cook Medical Group
13.1.10. Endologix Inc.
13.1.11. Evasc Medical Systems Corp.
13.1.12. Integra Lifesciences Corporation
13.1.13. iVascular S.L.U.
13.1.14. Johnson & Johnson Services, Inc.
13.1.15. Koninklijke Philips N.V.
13.1.16. Lepu Medical Technology(Beijing)Co.,Ltd.
13.1.17. Medical Murray
13.1.18. Medtronic PLC
13.1.19. Microvention Inc.
13.1.20. Penumbra, Inc.
13.1.21. Phenox GmbH by Wallaby Medical
13.1.22. Rapid Medical Ltd.
13.1.23. Scientia Vascular, Inc.
13.1.24. Secant Group, LLC
13.1.25. Stryker Corporation
13.1.26. Terumo Corporation
13.1.27. W. L. Gore & Associates, Inc.
13.1.28. Zeus Company Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. NEUROVASCULAR DEVICES MARKET RESEARCH PROCESS
FIGURE 2. NEUROVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NEUROVASCULAR DEVICES MARKET DYNAMICS
FIGURE 7. NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2030 (%)
FIGURE 8. NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2030 (%)
FIGURE 10. NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. NEUROVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings